EGFR and non-small cell lung carcinoma: Cur also directly suppresses the levels of Toll-like receptor 4 (TLR4)/MyD88 and EGFR, thereby controlling cell cycle and epithelial–mesenchymal transition (EMT)-related checkpoints and repressing cell growth and invasion in NSCLC [29].